Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
October 04, 2024 10:31 ET
|
Compass Therapeutics
BOSTON, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Immune Checkpoint Inhibitors Market to hit USD 189.1 billion by 2032, says Global Market Insights Inc.
October 01, 2024 05:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...
Proteomics Market Size To Reach USD 92.8 Billion By 2033, At 14.7% CAGR: Insights by Dimension Market Research
September 10, 2024 11:09 ET
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Proteomics Market size is expected to reach USD 27.0 billion by 2024 and it is further anticipated to reach a market value of USD...
Precision Medicine Market Is Expected To Reach Revenue Of USD 225.7 Bn By 2033, At 11.6% CAGR: Dimension Market Research
September 10, 2024 11:03 ET
|
Dimension Market Research
New York, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global Precision Medicine Market is to reach USD 83.9 billion by 2024 and is further anticipated to reach USD 225.7 billion by 2033...
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
August 29, 2024 08:27 ET
|
Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Dementia Mission Competition Selects Four Companies For Innovative Alzheimer’s Biomarker Study
July 10, 2024 09:05 ET
|
Global Alzheimer’s Platform Foundation®
Washington D.C., July 10, 2024 (GLOBE NEWSWIRE) -- With groundbreaking creativity and breathtaking speed, this phase 3 competition, funded by Innovate UK, the UK’s innovation agency, is supporting...
Personalized Medicine Biomarker Market Size to Reach USD 72.7 Billion By 2033, at 17.5 CAGR: Insights by Dimension Market Research
July 01, 2024 11:34 ET
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Personalized Medicine Biomarker Market size is expected to reach USD 17.0 billion by 2024 and it is further anticipated to reach...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Biomarkers Market is Expected to Reach $93.8 billion | MarketsandMarkets™
May 14, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 14, 2024 (GLOBE NEWSWIRE) -- Biomarkers market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at a CAGR of...
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
April 04, 2024 08:11 ET
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.